Title 21 Part 866 → Subpart D → §866.3310

Title 21 → Chapter I → Subchapter H → Part 866 → Subpart D → §866.3310

Electronic Code of Federal Regulations e-CFR

Title 21 Part 866 → Subpart D → §866.3310

e-CFR data is current as of May 26, 2020

Title 21Chapter ISubchapter HPart 866Subpart D → §866.3310

Title 21: Food and Drugs
Subpart D—Serological Reagents

§866.3310   Hepatitis A virus (HAV) serological assays.

(a) Identification. HAV serological assays are devices that consist of antigens and antisera for the detection of hepatitis A virus-specific IgM, IgG, or total antibodies (IgM and IgG), in human serum or plasma. These devices are used for testing specimens from individuals who have signs and symptoms consistent with acute hepatitis to determine if an individual has been previously infected with HAV, or as an aid to identify HAV-susceptible individuals. The detection of these antibodies aids in the clinical laboratory diagnosis of an acute or past infection by HAV in conjunction with other clinical laboratory findings. These devices are not intended for screening blood or solid or soft tissue donors.

(b) Classification. Class II (special controls). The special control is “Guidance for Industry and FDA Staff: Class II Special Controls Guidance Document: Hepatitis A Virus Serological Assays.” See §866.1(e) for the availability of this guidance document.

[71 FR 6679, Feb. 9, 2006]